1. Home
  2. SBCF vs AMPH Comparison

SBCF vs AMPH Comparison

Compare SBCF & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SBCF

Seacoast Banking Corporation of Florida

HOLD

Current Price

$31.56

Market Cap

3.2B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.40

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBCF
AMPH
Founded
1926
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
1.2B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
SBCF
AMPH
Price
$31.56
$26.40
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$31.00
$31.00
AVG Volume (30 Days)
810.8K
367.6K
Earning Date
01-26-2026
11-06-2025
Dividend Yield
2.40%
N/A
EPS Growth
23.57
N/A
EPS
1.68
2.27
Revenue
$556,541,000.00
$723,305,000.00
Revenue This Year
$33.11
$1.35
Revenue Next Year
$29.90
$5.10
P/E Ratio
$18.82
$11.66
Revenue Growth
12.63
N/A
52 Week Low
$21.36
$20.39
52 Week High
$33.23
$39.01

Technical Indicators

Market Signals
Indicator
SBCF
AMPH
Relative Strength Index (RSI) 46.69 49.11
Support Level $31.48 $26.26
Resistance Level $32.58 $27.23
Average True Range (ATR) 0.62 0.77
MACD -0.16 -0.00
Stochastic Oscillator 34.44 52.68

Price Performance

Historical Comparison
SBCF
AMPH

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage and credit facilities.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: